Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul N Durrington

Showing results (81-90 of 106) with videos related to

Pageof 11
Sort By:
Lancet (London, England)|August 25, 2004
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trialHelen M Colhoun, D John Betteridge, Paul N Durrington, et al.
Diabetes & Vascular Disease Research|April 25, 2019
Bariatric surgery as a model to explore the basis and consequences of the Reaven hypothesis: Small, dense low-density lipoprotein and interleukin-6Safwaan Adam, Yifen Liu, Tarza Siahmansur, et al.
Clinical Chemistry|January 17, 2009
Targets of statin therapy: LDL cholesterol, non-HDL cholesterol, and apolipoprotein B in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS)Valentine Charlton-Menys, D John Betteridge, Helen Colhoun, et al.
Journal of Nephrology|December 19, 2006
Paraoxonase gene polymorphism and serum activity in progressive IgA nephropathyTibor J Kovács, Shelley Harris, Tibor K Vas, et al.
Atherosclerosis|March 5, 2022
Glycated apolipoprotein B decreases after bariatric surgery in people with and without diabetes: A potential contribution to reduction in cardiovascular riskZohaib Iqbal, Bilal Bashir, Safwaan Adam, et al.
Clinical Therapeutics|May 4, 2010
Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: a 12-week, multicenter, randomized, double-blind, controlled trialRoeland Huijgen, Evertine J Abbink, Eric Bruckert, et al.
Obesity Surgery|December 10, 2021
Bariatric Surgery Leads to a Reduction in Antibodies to Apolipoprotein A-1: a Prospective Cohort StudySafwaan Adam, Jan H Ho, Yifen Liu, et al.
The Journal of Clinical Endocrinology and Metabolism|May 31, 2022
Bariatric Surgery-induced High-density Lipoprotein Functionality Enhancement Is Associated With Reduced InflammationSafwaan Adam, Jan H Ho, Yifen Liu, et al.
Metabolites|May 26, 2023
Severe Hypertriglyceridaemia and Chylomicronaemia Syndrome-Causes, Clinical Presentation, and Therapeutic OptionsBilal Bashir, Jan H Ho, Paul Downie, et al.
Journal of the American College of Cardiology|October 31, 2009
Effects of high-dose modified-release nicotinic acid on atherosclerosis and vascular function: a randomized, placebo-controlled, magnetic resonance imaging studyJustin M S Lee, Matthew D Robson, Ly-Mee Yu, et al.
Pageof 11

Showing results (81-90 of 106) with videos related to

Sort By:
Pageof 11
Lancet (London, England)|August 25, 2004
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trialHelen M Colhoun, D John Betteridge, Paul N Durrington, et al.
Diabetes & Vascular Disease Research|April 25, 2019
Bariatric surgery as a model to explore the basis and consequences of the Reaven hypothesis: Small, dense low-density lipoprotein and interleukin-6Safwaan Adam, Yifen Liu, Tarza Siahmansur, et al.
Clinical Chemistry|January 17, 2009
Targets of statin therapy: LDL cholesterol, non-HDL cholesterol, and apolipoprotein B in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS)Valentine Charlton-Menys, D John Betteridge, Helen Colhoun, et al.
Journal of Nephrology|December 19, 2006
Paraoxonase gene polymorphism and serum activity in progressive IgA nephropathyTibor J Kovács, Shelley Harris, Tibor K Vas, et al.
Atherosclerosis|March 5, 2022
Glycated apolipoprotein B decreases after bariatric surgery in people with and without diabetes: A potential contribution to reduction in cardiovascular riskZohaib Iqbal, Bilal Bashir, Safwaan Adam, et al.
Clinical Therapeutics|May 4, 2010
Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: a 12-week, multicenter, randomized, double-blind, controlled trialRoeland Huijgen, Evertine J Abbink, Eric Bruckert, et al.
Obesity Surgery|December 10, 2021
Bariatric Surgery Leads to a Reduction in Antibodies to Apolipoprotein A-1: a Prospective Cohort StudySafwaan Adam, Jan H Ho, Yifen Liu, et al.
The Journal of Clinical Endocrinology and Metabolism|May 31, 2022
Bariatric Surgery-induced High-density Lipoprotein Functionality Enhancement Is Associated With Reduced InflammationSafwaan Adam, Jan H Ho, Yifen Liu, et al.
Metabolites|May 26, 2023
Severe Hypertriglyceridaemia and Chylomicronaemia Syndrome-Causes, Clinical Presentation, and Therapeutic OptionsBilal Bashir, Jan H Ho, Paul Downie, et al.
Journal of the American College of Cardiology|October 31, 2009
Effects of high-dose modified-release nicotinic acid on atherosclerosis and vascular function: a randomized, placebo-controlled, magnetic resonance imaging studyJustin M S Lee, Matthew D Robson, Ly-Mee Yu, et al.
Pageof 11